Allspring Global Investments Holdings LLC decreased its position in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 11.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 355,627 shares of the company’s stock after selling 44,337 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in BlackRock Health Sciences Term Trust were worth $5,633,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of BMEZ. Sanctuary Advisors LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the second quarter worth $3,179,000. Quarry LP lifted its position in BlackRock Health Sciences Term Trust by 304.9% during the 2nd quarter. Quarry LP now owns 98,886 shares of the company’s stock worth $1,519,000 after buying an additional 74,463 shares in the last quarter. Almitas Capital LLC boosted its stake in shares of BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after buying an additional 831,025 shares during the last quarter. Sessa Capital IM L.P. increased its position in shares of BlackRock Health Sciences Term Trust by 27.1% in the second quarter. Sessa Capital IM L.P. now owns 1,853,022 shares of the company’s stock valued at $28,462,000 after acquiring an additional 395,288 shares during the last quarter. Finally, Logan Stone Capital LLC bought a new stake in BlackRock Health Sciences Term Trust during the second quarter worth about $1,770,000.
BlackRock Health Sciences Term Trust Stock Performance
BMEZ stock opened at 15.54 on Monday. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.59. The business has a 50 day moving average price of 15.85 and a two-hundred day moving average price of 15.48.
BlackRock Health Sciences Term Trust Announces Dividend
Insider Buying and Selling
In other news, major shareholder Saba Capital Management, L.P. bought 29,795 shares of the company’s stock in a transaction dated Wednesday, October 16th. The shares were bought at an average cost of 15.81 per share, with a total value of 471,058.95. Following the acquisition, the insider now owns 20,750,913 shares in the company, valued at 328,071,934.53. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Over the last three months, insiders have bought 99,630 shares of company stock worth $1,585,113.
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Articles
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What is an Earnings Surprise?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- The Basics of Support and Resistance
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Invest in Insurance Companies: A Guide
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.